Bridgewater Associates’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.56M Sell
594,483
-314,742
-35% -$2.37M 0.02% 498
2025
Q4
$6.52M Buy
909,225
+240,538
+36% +$1.9M 0.02% 456
2025
Q3
$7.14M Buy
668,687
+480,251
+255% +$4.71M 0.03% 405
2025
Q2
$1.82M Buy
188,436
+120,139
+176% +$1.24M 0.01% 427
2025
Q1
$1.02M Buy
68,297
+50,250
+278% +$773K ﹤0.01% 520
2024
Q4
$269K Sell
18,047
-185,149
-91% -$3.02M ﹤0.01% 641
2024
Q3
$3.89M Buy
+203,196
New +$4.21M 0.02% 413

Other funds holding OGN

Bridgewater Associates's OGN Position: Q1 2026 in Review

Bridgewater Associates reduced its Organon & Co (OGN) stake by 35% in Q1 2026, selling an estimated $2.37M and leaving 594,483 shares worth $3.56M. The position accounts for 0.02% of the portfolio, ranked #498.

Bridgewater Associates first reported a position in OGN in Q3 2024 and has held it in 7 quarters since. The position peaked at $7.14M in Q3 2025. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Bridgewater Associates held 594,483 shares of Organon & Co worth $3.56M as of Q1 2026.
  • Bridgewater Associates sold 314,742 Organon & Co shares in Q1 2026, an estimated $2.37M.
  • Organon & Co made up 0.02% of Bridgewater Associates's portfolio in Q1 2026, its #498 holding.
  • Bridgewater Associates first reported a position in Organon & Co in Q3 2024 and has held it in 7 quarters since.
  • Bridgewater Associates's Organon & Co position peaked at $7.14M in Q3 2025.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.